US FDA panel to weigh Isolagen's cell therapy for wrinkles
This article was originally published in Scrip
Executive Summary
The US FDA's outside experts will convene on October 9th to discuss Isolagen Technologies' BLA for its first-in-class autologous cellular therapy Isolagan Therapy for the treatment of wrinkles.